If you are asking whether Synthesis Peptides is legit or a scam, you are asking before you pay, which is the right moment. Synthesis Peptides sells peptides for research use, and a research-use label means not for human use. Whether this seller is legit is something you can check yourself: who runs the shop, whether the certificate of analysis (COA) matches the vial you would receive, and whether its refund and renewal terms are written and consistent. The new federal peptide policy published October 30, 2026 does not apply to products sold as research chemicals, so it does not change these checks.
Disclosure: A number of the links on this page are affiliate links. When you purchase through them, this publication may be paid a commission. Your price is the same either way.
| Key fact | What it means for you |
|---|---|
| Federal policy | HHS interim enforcement discretion covers six peptides. It was published October 30, 2026, and comments close November 13, 2026. |
| Research chemicals | Products sold as research chemicals are not covered by the policy. Synthesis Peptides sells its vials for research use. |
| Label | A research-use label means not for human use. |
| Prescription route | The policy route runs through a patient-specific prescription and a covered compounder. |
| Price | Prices and bundles change. Check today’s price directly with the seller before you order. |
| Refund terms | Ask the seller for its written refund, return and cancellation terms before you pay. |
| Check date | November 2, 2026 |
Quick facts
| Item | Detail |
|---|---|
| Seller | Synthesis Peptides, an online shop that sells peptide vials for research use |
| Product type | Peptide vials sold for research use |
| Human use | The seller’s research-use label means not for human use |
| HHS policy | Interim enforcement discretion for six peptides, in set forms and routes; research chemicals are excluded |
| Prescription | The policy route requires a patient-specific prescription and a covered compounder |
| Price | Prices and bundles change. Check today’s price on the seller’s shop before you order. |
| Refund and cancellation | Ask the seller for its written terms before you pay, and save a copy |
| Check date | November 2, 2026 |
| Product Page | Product Page |
What is Synthesis Peptides, and what is it not?
Synthesis Peptides is an online shop for peptides, and you can reach it through the Product Page. It sells its vials for research use. That is a different category from the compounded medicines the new federal policy describes. For a general primer on peptide types, read our exploring peptides guide.
The policy route runs through a licensed prescriber, a covered compounder and a patient-specific prescription. A research vial bought online does not follow that route, so keep the two apart as you read the rest of this page.
What is the new federal peptide policy?
HHS says it does not intend to take enforcement action against a State-licensed pharmacy, a Federal facility or a licensed physician who compounds one of six peptides, when the conditions in its policy are met. The policy was published in the Federal Register policy notice on October 30, 2026, and comments close November 13, 2026. It is an interim policy. It is not FDA approval, it does not add these peptides to the 503A bulks list, and HHS may revise or withdraw it if a safety signal or product quality problem arises. The HHS policy text is the primary document to read.
The six peptides, in the forms and routes the policy names, are listed below. LegitScript’s policy summary sets out the same list.
| Peptide | Form covered | Routes covered |
|---|---|---|
| BPC-157 | Acetate | Subcutaneous, intramuscular, oral, topical |
| TB-500 | Acetate | Subcutaneous, intramuscular |
| Epitalon | Acetate | Subcutaneous, intramuscular |
| Semax | Free base | Intranasal |
| KPV | Acetate | Topical, oral |
| MOTS-c | Acetate | Subcutaneous, intramuscular |
LegitScript counts ten conditions in the policy. These are the ones a buyer most needs to understand.
| Condition | What it requires |
|---|---|
| Covered peptide | Only the six peptides, in the listed form and route |
| Sourcing | FDA-registered sourcing and a valid COA from a facility registered under section 510 |
| Original manufacturer | The original manufacturer must be FDA-registered and follow current good manufacturing practice, and its physical location must appear on the COA |
| Reporting | Compounded products, serious adverse events and product quality issues must be reported to FDA and the relevant states |
| Label | “This is a compounded drug product. Not for resale.” |
| Single ingredient | One active ingredient only. LegitScript reads this as excluding combinations, such as BPC-157 with TB-500. |
| Oral forms | Documentation that the specific formulation reaches adequate oral bioavailability in humans |
| Devices | Any co-packaged delivery device must be an FDA 510(k)-cleared syringe |
| Prescription | A patient-specific prescription, plus the other applicable requirements |
The policy does not cover 503B outsourcing facilities. The BakerHostetler policy summary also says it does not apply to products sold as research chemicals or dietary supplements. For the full route list, read our six-peptide route guide.
Who may fit, and who should pause?
If a licensed prescriber has written you a patient-specific prescription and a covered compounder is filling it, the policy route is the one that applies to you. Whether one of the six fits your situation is a decision for that prescriber.
If you are looking at a research vial, the policy does not apply to it, and the label already states the seller’s position: not for human use.
Pause before you consider any peptide for your own health, and talk with a clinician first, especially if you take any medicine.
How does the offer work?
Synthesis Peptides offers research vials through its shop. The compounded route works differently. A licensed prescriber writes a patient-specific prescription, and a State-licensed pharmacy or licensed physician compounds the peptide from FDA-registered sourcing with a valid COA. Compare the two before you decide which one you are looking at.
The peptide named on the vial is the ingredient you are buying. Check that name against the COA for that lot before you rely on it.
What does the research show about these peptides?
What is established
- FDA’s FDA bulk substances safety risk page lists BPC-157, TB-500, epitalon, KPV, MOTS-c and semax among substances that may present significant safety risks. HHS says each was in Category 2 from September 2023 until April 22, 2026, and that neither the placement nor the removal changed its status under section 503A.
- In July 2026, FDA’s Pharmacy Compounding Advisory Committee narrowly voted to recommend adding six peptides to the 503A list. The vote is non-binding. FDA staff scientists had unanimously opposed adding every peptide, citing a lack of solid clinical trial data, according to the ABC News report on the July vote.
- In briefing materials reported by The Hill on FDA briefing materials, FDA reviewers said there was a lack of evidence to conclude that BPC-157 is effective for ulcerative colitis.
- The Associated Press report via NBC News says most of the data on peptides comes from animal studies.
What the seller says
Synthesis Peptides sells its vials for research use, and its label says not for human use. Check the seller’s own pages and the paperwork for each lot you are considering.
Our analysis
The policy does not cover products sold as research chemicals, so its prescription, sourcing, labeling and reporting conditions do not apply to a research vial. The COA for that lot is the document that describes what is in the vial, so compare it with the label on the vial you receive.
Open questions
- Whether HHS finalizes, revises or withdraws the policy after comments close on November 13, 2026.
- Whether the seller provides a COA for your lot, and which laboratory tested it.
- Which license the seller means if it uses the word “licensed.”
- Whether advertising platforms and payment processors keep serving these products. LegitScript says its certification does not guarantee access to them.
Do any peptides actually work?
For the six peptides in the policy, human data is limited. FDA reviewers said there was a lack of evidence to conclude that BPC-157 is effective for ulcerative colitis, and the Associated Press reports that most peptide data comes from animal studies. The AP also reports that people buy these peptides for uses such as building muscle, looking younger and boosting energy, and that the FDA has not approved those uses. Insulin and GLP-1 medicines are a different case. ABC News describes them as FDA-approved medicines that have been rigorously tested.
For what the existing trials found, see what peptides trials found (our research library).
What does it cost, and what is the total?
Prices and bundles change, so check today’s price directly with the seller on the Product Page before you order. Add up the whole order before you pay: the vial price for the size you choose, any multi-unit discount, shipping, taxes, any recurring charge, and whether anything renews automatically.
On the prescription route, ask the prescriber and the pharmacy for the full cost before you start.
What are the side effects and risks, and who is eligible?
FDA’s risk page is the clearest published statement of what the agency has flagged for these peptides. It is current as of April 22, 2026.
| Peptide | FDA’s stated concern |
|---|---|
| BPC-157 | Possible immunogenicity risk from aggregation and impurities; FDA had no or only limited safety information for the proposed routes |
| TB-500 (thymosin beta-4 fragment) | FDA had identified no human exposure data for drug products containing it, and lacked information on safety issues |
| Epitalon | Possible immunogenicity risk from aggregation and impurities; no safety information identified for the proposed route |
| KPV | FDA had identified no human exposure data, and lacked important information on safety issues |
| MOTS-c | Possible significant immunogenicity risk for certain routes; FDA had identified no human exposure data |
| Semax | Possible immunogenicity risk; no or limited safety information for the proposed routes |
| GHK-Cu (injectable routes) | Possible immunogenicity risk from aggregation and impurities; limited data in humans |
FDA says it lacks sufficient information to know whether several of these would cause harm in humans.
FDA’s list describes each concern and does not rank the peptides. Other peptides on the same list have described more serious events. FDA names increased heart rate and a systemic vasodilatory reaction for CJC-1295, and published case reports discuss melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome and priapism for Melanotan II.
Compounded drugs have a documented record of harm. A University of Maryland compounding overview reports that a 2012 fungal meningitis outbreak, linked to contaminated steroid injections from the New England Compounding Center, led to more than 60 deaths and 750 cases of infection.
Reporting rules have changed. A 2023 compounding review in PMC notes that, except for 503B facilities, compounding pharmacies were not required to report adverse events to FDA. Under the policy’s conditions, covered compounders must report serious adverse events and product quality issues to FDA and the states, as LegitScript summarizes it.
Eligibility is narrow in practice. Oral forms need bioavailability documentation, injection devices must be FDA 510(k)-cleared syringes, and combinations do not qualify under LegitScript’s reading. For a broader view of side effects, see are peptides dangerous.
Is Synthesis Peptides legit? How to run the checks
Legitimacy is about the business, the paperwork and the written terms. Run each check below and write down what you find.
Who runs the shop?
Check the business name shown at checkout and in the site’s terms. Search that name in your state’s business registration records. Then send a pre-order question by email and see whether the reply is specific.
Does a license claim hold up?
If a site says “licensed” without naming the license, ask in writing which license it means and what it covers. A license you can look up with a state board is a claim you can check. A word on a homepage is only a claim.
Could it be a look-alike site?
Type the shop address yourself rather than tapping a link in an ad or a video. Check that it matches the address in your order confirmation.
Does the COA match your vial?
The federal compounding statute says bulk drug substances must come from an establishment registered under section 360, and must be accompanied by valid certificates of analysis for each bulk drug substance. Use the same standard for a research vial:
- The lot number on your vial matches the lot on the COA.
- The peptide name on the COA matches the vial. A blend needs a certificate for the blend.
- The laboratory that tested the lot is named, and you can contact it.
- Purity and measured content appear as separate figures.
Testing can reveal problems. The Partnership for Safe Medicines news page reports that CBS News bought peptides at a New York City bodega and sent the vials to the University of Iowa. One vial sold as retatrutide contained no retatrutide, and researchers said it did not contain a peptide at all, but 13 bacterial colonies.
Refunds, cancellations and renewals
Get the seller’s written refund, return, cancellation and renewal terms before you pay, and save a copy. Confirm the window for reporting a problem with an order, and whether anything renews automatically. If two pages from the same seller give different answers, ask in writing which one applies.
Red flags in sales copy
LegitScript, a third-party certification organization, lists these signals that marketing has moved into promotion, in its LegitScript guidance on promotional signals:
- Saying a peptide repairs or heals a specific condition.
- Making efficacy or safety claims compared with FDA-approved medicines.
- Giving dosing advice for an unapproved drug.
- Calling a peptide proven or science-backed without saying most research has not been done in humans.
- Stating that a product is FDA-approved or legally permitted for compounding.
The Partnership for Safe Medicines news page also reports that a group of senators urged FDA to act against vendors who misuse “research use only” labels to sell unapproved drugs.
Ad and payment access
LegitScript says its certification does not guarantee that advertising platforms or payment providers will serve a business. Ask what happens to your order if a payment or shipping provider changes.
Has a company shut down?
Check what the company does now: whether its contact details work, whether it ships, and whether it answers refund requests. FDA’s FDA compounding warning letters and recalls page lets you search its warning letter database for the term “telehealth” and the Enforcement Report for compounding recalls.
How do refunds and shipping work?
Ask the seller in writing for its refund, return, cancellation and renewal terms before you pay, and keep a copy. Confirm what happens if an item arrives damaged, and the deadline for reporting it. Check the carrier, delivery timing and order cutoff at checkout, and get the answer in writing if it matters to you.
Are there alternatives, including doing nothing?
| Option | What it involves | What to check |
|---|---|---|
| Research vial from a seller | Bought for research use. The label means not for human use. The HHS policy does not cover it. | The COA for your lot, the lab named, and written refund terms |
| Compounded route under the policy | A patient-specific prescription, and compounding by a State-licensed pharmacy or licensed physician, for one of the six peptides in the listed form and route | Whether the pharmacy meets the conditions, including FDA-registered sourcing and a COA |
| FDA-approved medicines for your goal | ABC News describes insulin and GLP-1 medicines as FDA-approved medicines that have been rigorously tested | Which approved option fits your condition, decided with a clinician |
| Doing nothing | No purchase, and no vial to verify | Revisit the question after the November 13, 2026 comment deadline and any final HHS action |
For more on what each peptide is, read what peptides are fda approved, and our HHS unapproved peptides compounding guide.
Which questions settle the decision?
| Question | What the answer means |
|---|---|
| Is the product sold for research use? | A research-use vial falls outside the HHS policy, so the policy’s prescription, sourcing, labeling and reporting conditions do not apply to it. |
| Is there a patient-specific prescription from a licensed prescriber? | That is the route the policy describes. Without it, the policy does not apply. |
| Is the peptide one of the six, in the listed form and route? | Only those combinations appear in the policy. |
| Does the COA name the lab and match the lot on your vial? | If it does, you can check the report yourself. If the lab is not named, ask who tested it before you pay. |
| Are refund, cancellation and renewal terms written and consistent? | Terms that differ between pages are a reason to ask, in writing, which one applies. |
| Can you look up the license the site names? | A license you can look up is a stronger starting point than a homepage label. |
| Does a clinician who knows your history agree? | Clinician input decides fit. The policy does not. |
How do you verify before you pay?
- Write down the seller’s exact business name, and type the shop address yourself.
- Ask the seller in writing which license it means, which lab tested the lot you would receive, and for a copy of that lot’s COA.
- Ask for the refund window, the cancellation rule and whether the order renews.
- Compare the answers across the seller’s pages, and ask which version applies if they differ.
- If you are considering the policy route, check that the peptide is one of the six, in the listed form and route.
- If a telehealth service offers a peptide, check that it works through a covered compounder with a patient-specific prescription.
- Search FDA’s warning letters and compounding recalls for the company or service.
- Save screenshots of the product page, the checkout total, the refund page, the COA and the vial label.
- Talk with a clinician before any use, especially if you take medicine.
Quick answers to the other questions you may have
Is it legal to buy these peptides now?
HHS says it does not intend to take enforcement action against a State-licensed pharmacy, Federal facility or licensed physician who compounds one of the six peptides under the policy’s conditions. The policy does not cover research vials. It does not settle whether buying a research vial is lawful, so ask a pharmacist or an attorney in your state.
Can a doctor prescribe these peptides?
The policy covers licensed physicians compounding for a patient-specific prescription. Whether a particular clinician will prescribe one is that clinician’s decision.
How much does it cost?
Check today’s price directly with the seller on the Product Page, and add up the total as described in the cost section above. For a prescription, ask the prescriber and the pharmacy.
Is GHK-Cu FDA-approved for human use?
FDA’s risk page lists injectable GHK-Cu with a possible immunogenicity risk and limited data in humans. GHK-Cu is not among the six peptides in the HHS policy. To check its approval status, search FDA’s Drugs@FDA database or ask a pharmacist.
Are compounded medications regulated by the FDA?
Partly. The 2023 compounding review in PMC says state boards of pharmacy oversee the day-to-day activities of 503A pharmacies, while FDA regulates 503B outsourcing facilities. HHS’s policy states that compounded drugs are not FDA-approved, which means FDA does not review their safety, effectiveness or quality before they are marketed.
How do you tell a compounding pharmacy from an outsourcing facility?
A 503A pharmacy is state-licensed, regulated by its state board, and compounds for an identified patient on a prescription. A 503B outsourcing facility must register with FDA. The HHS policy covers 503A pharmacies, federal facilities and licensed physicians, and it does not cover 503B facilities.
Can you name the most trusted peptide company?
Trust comes from checks on each company, not from a ranking. Use the checklist above on any company you are considering, and compare them on what you can verify.
Does a celebrity use peptides?
A celebrity’s routine says nothing about a vendor’s products or its paperwork. Check the vendor with the list above.
By the Clinical Research Explained Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.